# Oakwood Laboratories

Source: https://onco.cc/companies/oakwood-laboratories/  
OnCo record `oakwood-laboratories` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Oakwood Laboratories is an Ohio specialist in long-acting injectable microspheres whose leuprolide depot formulations for prostate cancer went through the phase 3 trials it led.

## Summary

Oakwood Laboratories, founded in 1997 in Oakwood Village, Ohio, develops sustained-release injectable microsphere formulations. Its leuprolide acetate depot products for advanced prostate cancer, developed to match the established monthly and three-monthly injections, were taken through phase 3 trials registered on ClinicalTrials.gov under Oakwood as lead sponsor, and the company also contract-manufactures depots for partners.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Oakwood Laboratories, LLC; Oakwood Labs
- Tags: ctgov-sponsor
- HQ: Oakwood Village, OH
- Type: pharma
- Website: http://oakwoodlabs.com

## Sources

- Official website: http://oakwoodlabs.com
- ClinicalTrials.gov: trials led by Oakwood Laboratories, LLC: https://clinicaltrials.gov/search?lead=Oakwood%20Laboratories%2C%20LLC
- Wikidata: https://www.wikidata.org/wiki/Q30265419

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Leuprolide (leuprorelin) and GnRH agonists](https://onco.cc/drugs/leuprolide/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/oakwood-laboratories.json